abathresearch

abathresearch | Joined since 2019-06-17

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

10

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
10
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2021-02-22 10:50 | Report Abuse

Lol... then stay in a cave lor no need to come out very safe

Stock

2021-02-09 17:28 | Report Abuse

https://www.rev.com/blog/transcripts/white-house-covid-19-response-team-dr-fauci-press-conference-transcript-february-5

Tim Manning: (15:02)
And third, we’re very focused on procuring the personal protective equipment, PPE, to keep America’s frontline healthcare workers safe. There’s a grave need for masks, shields, and gloves, and we currently aren’t producing these at the rate we need in order to keep up with demand. We’re already working to increase the availability of N95 masks to frontline workers, but another critical area of concern we hear over and over is surgical gloves. Right now, we just don’t have enough gloves. We’re nearly 100% reliant on overseas manufacturers to export to us our country’s surgical gloves that protect healthcare workers. And that’s unacceptable, and we’re using all of our authorities to fix it. Over the past two weeks, we’ve pushed forward in effort to expand domestic manufacturing of surgical gloves. And I’m pleased to announce that we will build plants to make the raw materials, the nitro butyl rubber for surgical gloves, here in the United States, and we’ll help build factories to make those gloves right here in the US as well. And by the end of-

Tim Manning: (16:03)
Factories to make those gloves right here in the US as well. And by the end of the year, we’ll produce more than a billion nitrile gloves a month right here in America. We’ll now make enough to satisfy half of all the US healthcare community demands right here on US shores. These are just three examples of how we’re using the DPA strategically and effectively in our national response, and there’s more to come. I know there’s a great deal of interest in exactly where and with whom we’re contracting. For reasons of procurement law, I’m not able to disclose the ongoing contract negotiations until they’re finalized. Efficient contracts take four to five weeks to finalize, and we’re about halfway through. So over the next few weeks, I expect we’ll have more announcements about the ways we’re using the DPA and other tools to combat the virus. Now, I want to end by encouraging Congress to act because some of our additional plans to use DPA, including adding more domestic genomic sequencing, allowing us to track variants and seeing new ones or ramp up molecular tests require funding. Congress could help this effort greatly by passing the American Rescue plan. And with that, I’ll turn it back over to Andy.

Stock
Stock

2019-08-30 01:08 | Report Abuse

Please read our thoughts on Carimin's 4Q19 results at https://abathresearch.finance.blog/

Stock

2019-08-23 15:30 | Report Abuse

Results for Carimin likely out on the 29th. Tonight watch out for Dayang.

Stock

2019-07-10 11:13 | Report Abuse

Uzma I will only buy if the owner starts buying back. Which is also the angle of our recent research report. https://abathresearch.finance.blog/

Stock

2019-07-01 13:43 | Report Abuse

Switch to Uzma. Lol.